Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. The company develops paclitaxel polymer micelle for treatment of small cell lung cancer. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $3.72 | N/A |
Market Cap | $589.46M | N/A |
Shares Outstanding | 158.28M | N/A |
Employees | 243.00 | N/A |